Company · CIK 0001385818 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
AYTU BIOPHARMA, INC · AYTU
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 AForm 4 → | Jul 30, 4:34 pm EDT | Joshua R. DisbrowChief Executive Officer, Director | 30,000 | — | — | 237,203 | — | |
| Jul 28, 2026 AForm 4 → | Jul 30, 4:34 pm EDT | Greg PyszczymukaChief Commercial Officer | 20,000 | — | — | 56,102 | — | |
| Jul 28, 2026 AForm 4 → | Jul 30, 4:33 pm EDT | Jarrett DisbrowChief Business Officer | 15,000 | — | — | 76,568 | — | |
| Jul 28, 2026 AForm 4 → | Jul 30, 4:33 pm EDT | Ryan J SelhornChief Financial Officer | 25,000 | — | — | 74,743 | — | |
| Jul 28, 2026 AForm 4 → | Jul 30, 4:32 pm EDT | Vivian H LiuDirector | 10,000 | — | — | 29,825 | — | |
| Jul 28, 2026 AForm 4 → | Jul 30, 4:31 pm EDT | Abhinav JainDirector | 10,000 | — | — | 29,500 | — | |
| Jul 28, 2026 AForm 4 → | Jul 30, 4:31 pm EDT | Carl DockeryDirector | 10,000 | — | — | 31,152 | — | |
| Jul 28, 2026 AForm 4 → | Jul 30, 4:31 pm EDT | John Donofrio Jr.Director | 10,000 | — | — | 23,762 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.